Cystatin C-Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals.

Sarah A van Eeghen Chantal Maria WiepjesGuy T'SjoenNatalie J Nokoff Martin den HeijerPetter BjornstadDaniël H van Raalte

Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)

In this cohort of transgender individuals, cystatin C-based eGFR increased with estradiol and anti-androgen therapy and decreased with testosterone therapy.

Keyphrases

small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
mental health
stem cells
bone marrow
smoking cessation
hiv infected